Evidence map›Paper›PMID 38489299›Full record

ArticlePloS one2024

A fluorescence viewer for rapid molecular assay readout in space and low-resource terrestrial environments.

Kristoff Misquitta, Bess M Miller, Kathryn Malecek, Emily Gleason, Kathryn Martin, Chad M Walesky, Kevin Foley, D Scott Copeland, Ezequiel Alvarez Saavedra, Sebastian Kraves

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Kristoff MisquittaStuyvesant High School, New York, NY, United States of America.
Bess M MillerDivision of Genetics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States of America.
Kathryn MalecekMassachusetts Institute of Technology, Cambridge, MA, United States of America.
Emily GleasonminiPCR bio, Cambridge, MA, United States of America.
Kathryn MartinminiPCR bio, Cambridge, MA, United States of America.ORCID 0000-0002-6495-5557
Chad M WaleskyDivision of Genetics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States of America.
Kevin FoleyBoeing Defense, Space & Security, Berkeley, MO, United States of America.
D Scott CopelandBoeing Defense, Space & Security, Berkeley, MO, United States of America.
Ezequiel Alvarez SaavedraminiPCR bio, Cambridge, MA, United States of America.
Sebastian KravesminiPCR bio, Cambridge, MA, United States of America.ORCID 0000-0002-6153-8029
Boeing (United States) · USBrigham and Women's Hospital · USMassachusetts Institute of Technology · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fluorescence-based assays provide sensitive and adaptable methods for point of care testing, environmental monitoring, studies of protein abundance and activity, and a wide variety of additional applications. Currently, their utility in remote and low-resource environments is limited by the need for technically complicated or expensive instruments to read out fluorescence signal. Here we describe the Genes in Space Fluorescence Viewer (GiS Viewer), a portable, durable viewer for rapid molecular assay readout that can be used to visualize fluorescence in the red and green ranges. The GiS Viewer can be used to visualize any assay run in standard PCR tubes and contains a heating element. Results are visible by eye or can be imaged with a smartphone or tablet for downstream quantification. We demonstrate the capabilities of the GiS Viewer using two case studies-detection of SARS-CoV-2 RNA using RT-LAMP and quantification of drug-induced changes in gene expression via qRT-PCR on Earth and aboard the International Space Station. We show that the GiS Viewer provides a reliable method to visualize fluorescence in space without the need to return samples to Earth and can further be used to assess the results of RT-LAMP and qRT-PCR assays on Earth.

Indexed as

COVID-19Biological AssayHumansMolecular Diagnostic TechniquesNucleic Acid Amplification TechniquesPoint-of-Care TestingRNA, ViralSARS-CoV-2Sensitivity and SpecificityRNA, Viral

Identifiers

PMID38489299
PMCPMC10942025
OpenAlexW4392857324

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.